Motif ID	Motif Logo	Scanned Score Distribution	Frequency of Motif	Replicability Score	Evolutionary Conservation Score	Gene Targets	Gene Ontology of CpGMM targets
CG_h9_promoter_p_RM_12_157_2			2	0.5	1.62E-04	ASL, XPOT	tRNA export from nucleus [BP], arginine biosynthetic process via ornithine [BP], argininosuccinate lyase activity [MF]
CG_h9_promoter_p_RM_12_68_6			3	0.5	1.10E-04	KDM1B	histone demethylase activity (H3-monomethyl-K4 specific) [MF]
CG_h9_promoter_p_RM_12_95_4			5	0.75	4.22E-04	PSEN2, RBPJ, NR4A1, SOX11, CDK8	positive regulation of BMP signaling pathway [BP], Notch signaling pathway [BP], RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription [MF]
CG_h9_promoter_p_RM_12_148_3			2	0.5	2.79E-04	EGR1, GAA, IFNAR2	diaphragm contraction [BP], sucrose metabolic process [BP], maltose metabolic process [BP], positive regulation of glomerular metanephric mesangial cell proliferation [BP], type I interferon binding [MF], vacuolar sequestering [BP]
CG_h9_promoter_p_RM_12_7_12			4	0.5	2.68E-04	SOX8, SOX9, SYNM, ZBTB16, RARA	ureteric bud development [BP], neurofilament cytoskeleton [CC], astrocyte fate commitment [BP], protein kinase A binding [MF], renal vesicle induction [BP], negative regulation of photoreceptor cell differentiation [BP], positive regulation of kidney development [BP], Sertoli cell development [BP], positive regulation of chondrocyte differentiation [BP], retinal rod cell differentiation [BP], positive regulation of branching involved in ureteric bud morphogenesis [BP], positive regulation of cartilage development [BP], male gonad development [BP], negative regulation of myoblast differentiation [BP], metanephric nephron tubule formation [BP], cell fate commitment [BP], Sertoli cell differentiation [BP], ureter morphogenesis [BP]
CG_h9_promoter_p_RM_12_14_2			3	0.5	2.35E-04	TRIB2, ENPP1, PCNT	olfactory bulb development [BP], negative regulation of fat cell differentiation [BP], negative regulation of interleukin-10 biosynthetic process [BP]
CG_h9_promoter_p_RM_12_45_5			3	0.75	2.77E-04	CYLD, CDC73, CCNE1	Wnt receptor signaling pathway [BP]
CG_h9_promoter_p_RM_12_97_2			3	0.5	3.86E-04	SKIL, AOC3	SMAD binding [MF], response to antibiotic [BP]
CG_h9_promoter_p_RM_12_24_2			3	0.5	3.66E-05	ABCG1, CAV1, AHR	lipid storage [BP], sterol-transporting ATPase activity [MF], detection of hormone stimulus [BP], cholesterol homeostasis [BP], cytosolic aryl hydrocarbon receptor complex [CC], cholesterol binding [MF], cholesterol transport [BP]
CG_h9_promoter_p_RM_12_155_4			2	0.5	2.31E-04	GMPR2, MEGF8, RHBDL1, SCIN, MAN1B1	endoplasmic reticulum quality control compartment [CC], calcium ion binding [MF], GMP reductase activity [MF]
CG_h9_promoter_p_RM_12_16_5			3	0.75	3.17E-04	MAN1A2, NLGN1, PVRL2	sperm mitochondrion organization [BP], positive regulation of synaptic vesicle endocytosis [BP], cell adhesion molecule binding [MF], virion attachment, binding of host cell surface coreceptor [BP], alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor clustering [BP], cytoskeletal matrix organization at active zone [BP], respiratory gaseous exchange [BP], positive regulation of synaptic vesicle exocytosis [BP], susceptibility to T cell mediated cytotoxicity [BP], positive regulation of ruffle assembly [BP], neurexin clustering [BP]
CG_h9_promoter_p_RM_12_89_6			3	0.75	3.46E-04	COG2, ARF1, AP2M1	intracellular protein transport [BP], regulation of defense response to virus by virus [BP]
CG_h9_promoter_p_RM_12_51_2			3	0.5	1.30E-04	HEXIM2, NR2F2, AQP6	radial pattern formation [BP], nitrate transmembrane transporter activity [MF], negative regulation of cyclin-dependent protein kinase activity [BP]
CG_h9_promoter_p_RM_12_169_4			2	0.5	2.17E-04	GRIA4, BCKDHA, GRIN1	3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [MF], synaptic cleft [CC], ionotropic glutamate receptor activity [MF], glutamate receptor signaling pathway [BP], alpha-ketoacid dehydrogenase activity [MF], ionotropic glutamate receptor signaling pathway [BP], extracellular-glutamate-gated ion channel activity [MF], propylene metabolic process [BP]
CG_h9_promoter_p_RM_12_160_4			2	0.5	1.72E-04	TFAP2B, SKI, PTGER4	cellular creatinine homeostasis [BP], cellular urea homeostasis [BP], negative regulation of integrin activation [BP], anterior/posterior axis specification [BP], negative regulation of eosinophil extravasation [BP], cellular ammonia homeostasis [BP]
CG_h9_promoter_p_RM_12_18_3			2	0.5	9.27E-05	FZD7, PFAS	negative regulation of ectodermal cell fate specification [BP], phosphoribosylformylglycinamidine synthase activity [MF]
CG_h9_promoter_p_RM_12_57_3			3	0.5	3.55E-04	ZFYVE27, CAPRIN1, PDLIM5	dendrite [CC], regulation of dendritic spine morphogenesis [BP]
CG_h9_promoter_p_RM_12_206_4			3	0.5	3.65E-04	C12orf44, PIK3C3	autophagic vacuole assembly [BP]
CG_h9_promoter_p_RM_12_184_6			3	0.5	2.76E-04	RGCC	positive regulation of gene expression involved in extracellular matrix organization [BP], positive regulation of extracellular matrix constituent secretion [BP], negative regulation of exit from mitosis [BP], regulation of M/G1 transition of mitotic cell cycle [BP], negative regulation of fibroblast growth factor production [BP]
CG_h9_promoter_p_RM_12_166_6			2	0.5	3.35E-04	BCL2L11, DISP1	BIM-BCL-2 complex [CC], BIM-BCL-xl complex [CC], patched ligand maturation [BP]
CG_h9_promoter_p_RM_14_15_1			1	0.25	3.37E-04	MALT1, POFUT1, TP73	B-1 B cell differentiation [BP], peptide-O-fucosyltransferase activity [MF], cerebrospinal fluid secretion [BP], protein O-linked fucosylation [BP], CBM complex [CC]
CG_h9_promoter_p_RM_12_208_3			3	0.75	2.39E-04	RCC1, HMGN4, FGF2, HOXC11	organ induction [BP], nucleosomal DNA binding [MF]
CG_h9_promoter_p_RM_12_178_3			2	0.5	2.58E-04	HGSNAT	heparan-alpha-glucosaminide N-acetyltransferase activity [MF]
CG_h9_promoter_p_RM_14_19_1			2	0.5	3.87E-04	GCDH	glutaryl-CoA dehydrogenase activity [MF]
CG_h9_promoter_p_RM_12_128_2			2	0.5	3.41E-04	WNT3A, ZBTB1, SMAD6, C11orf30, ZIC2, ZIC1, GZF1, ARID3A	embryonic pattern specification [BP], regulation of transcription, DNA-dependent [BP], positive regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation [BP], transcription, DNA-dependent [BP], positive regulation of mesodermal cell fate specification [BP], positive regulation of protein import into nucleus [BP]
CG_h9_promoter_p_RM_12_37_5			4	0.75	3.43E-04	VANGL2, SPTAN1	lateral plasma membrane [CC]
CG_h9_promoter_p_RM_12_140_2			2	0.5	4.49E-04	RNF5	ER-associated misfolded protein catabolic process [BP]
CG_h9_promoter_p_RM_12_39_2			3	0.5	2.60E-04	SOX1, G3BP1, MAEL, ARID5A, CENPW	DNA binding [MF], chromosome organization [BP]
CG_h9_promoter_p_RM_12_111_3			4	0.75	2.56E-04	SUV420H2, CRHR1, GRIN1	visual learning [BP], histone H4-K20 trimethylation [BP], corticotropin-releasing hormone receptor activity [MF], propylene metabolic process [BP]
CG_h9_promoter_p_RM_14_5_1			1	0.25	3.48E-05	D2HGDH	response to cobalt ion [BP], (R)-2-hydroxyglutarate dehydrogenase activity [MF]
CG_h9_promoter_p_RM_14_12_3			4	0.75	5.04E-04	SACM1L, RNF5	phosphatidylinositol-4-phosphate phosphatase activity [MF], ER-associated misfolded protein catabolic process [BP]
CG_h9_promoter_p_RM_14_10_2			3	0.75	2.93E-04	CDK10, CCNE1, ARHGEF1, APC2, CREBRF, FAM64A, MRPL49, HNRNPUL1, ARPC2	protein binding [MF], Arp2/3 complex binding [MF], AP-1 adaptor complex binding [MF], negative regulation of endoplasmic reticulum unfolded protein response [BP]
CG_h9_promoter_p_RM_12_142_2			4	0.5	4.12E-04	ATP2A2, ISL1, EGR1, TCEA2, ZIC2, SUPT6H	calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [MF], regulation of DNA-dependent transcription, elongation [BP], retinal ganglion cell axon guidance [BP], transcription regulatory region sequence-specific DNA binding [MF]
CG_h9_promoter_p_RM_12_35_2			2	0.5	1.94E-04	ARFGEF2	symmetric synapse [CC]
CG_h9_promoter_p_RM_14_17_1			2	0.5	3.95E-04	ING2	CCAAT-binding factor complex [CC], male germ-line stem cell division [BP]
CG_h9_promoter_p_RM_12_91_5			2	0.5	4.66E-04	ACTR5, PSMD14	double-strand break repair via homologous recombination [BP], DNA recombination [BP], double-strand break repair [BP], proteasome regulatory particle, lid subcomplex [CC]
CG_h9_promoter_p_RM_12_115_8			5	0.75	3.26E-04	CTF1, GNAS, TET1, MEIS1, HOXC6, ZHX2, NR2E1, DLX4, SPTBN4, MDK	behavior [BP], central nervous system projection neuron axonogenesis [BP], dentate gyrus development [BP], negative regulation of neuron differentiation [BP], behavioral fear response [BP], multicellular organismal development [BP], stem cell maintenance [BP], cell differentiation [BP], nervous system development [BP]
CG_h9_promoter_p_RM_12_64_4			3	0.75	3.77E-04	PDGFRA, NOS3, ATF4	negative regulation of platelet activation [BP], negative regulation of potassium ion transport [BP]
CG_h9_promoter_p_RM_14_1_9			4	0.5	4.66E-04	TBX4, GNAS, FGFR3	skeletal system morphogenesis [BP], endochondral ossification [BP], skeletal system development [BP]
CG_h9_promoter_p_RM_12_174_5			3	0.75	1.49E-04	TSSK4, BCL2L11, FZD7, CATSPER4, HUNK, ALKBH5, TGIF1, CLIC6	BIM-BCL-2 complex [CC], D4 dopamine receptor binding [MF], D2 dopamine receptor binding [MF], BIM-BCL-xl complex [CC], spermatogenesis [BP], negative regulation of ectodermal cell fate specification [BP], multicellular organismal development [BP], regulation of gastrulation [BP], cell differentiation [BP]
CG_h9_promoter_p_RM_12_10_4			3	0.75	3.76E-04	LSM11	U7 snRNA binding [MF]
CG_h9_promoter_p_RM_12_28_3			2	0.5	4.33E-04	SLC3A2	leucine import [BP]
CG_h9_promoter_p_RM_12_58_3			2	0.5	2.30E-04	ID2	positive regulation of transcription involved in G1/S phase of mitotic cell cycle [BP]
CG_h9_promoter_p_RM_12_144_3			2	0.5	4.34E-04	HLA-A, AANAT, RPS21, AP2M1	aralkylamine N-acetyltransferase activity [MF], endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [BP], regulation of defense response to virus by virus [BP]
CG_h9_promoter_p_RM_12_33_4			2	0.5	2.76E-04	FGF9, TP53INP2, SMO	osteoblast differentiation [BP], positive regulation of smoothened signaling pathway [BP], embryonic digestive tract development [BP]
CG_h9_promoter_p_RM_12_190_5			2	0.5	2.85E-04	DUT, SQLE, ACP1, PTPN18	squalene monooxygenase activity [MF], dUTP diphosphatase activity [MF], non-membrane spanning protein tyrosine phosphatase activity [MF], dUMP biosynthetic process [BP]
CG_h9_promoter_p_RM_12_93_4			2	0.5	2.38E-04	RNF187, TLX1, SMO, MARCKS, NRP2, ARIH2	otolith morphogenesis [BP], ventral midline determination [BP], detection of cell density by contact stimulus involved in contact inhibition [BP], protein K48-linked ubiquitination [BP], mesenchymal to epithelial transition involved in metanephric renal vesicle formation [BP], neuron differentiation [BP], neural crest cell migration [BP], germinal vesicle [CC]
CG_h9_promoter_p_RM_12_201_3			4	0.75	1.55E-04	IST1	virus budding from nuclear membrane by viral capsid re-envelopment [BP]
CG_h9_promoter_p_RM_12_49_5			3	0.5	2.43E-04	MAPK8IP1	JUN phosphorylation [BP], dentate gyrus mossy fiber [CC], dendritic growth cone [CC]
CG_h9_promoter_p_RM_14_7_1			2	0.5	2.06E-04	IL34	macrophage colony-stimulating factor receptor binding [MF]
CG_h9_promoter_p_RM_12_113_3			5	0.5	3.10E-04	TSHZ1, SIX3, SOX9, NRG3, FGF2, RARA	ureteric bud development [BP], chondroblast differentiation [BP], protein kinase A binding [MF], cartilage development [BP], sequence-specific DNA binding [MF], positive regulation of phosphatidylinositol 3-kinase cascade [BP], pattern specification process [BP], mammary gland development [BP], ERK1 and ERK2 cascade [BP], Sertoli cell differentiation [BP]
CG_h9_promoter_p_RM_12_19_4			3	0.75	2.73E-04	HLA-A, JMY, HCK	positive regulation of actin filament polymerization [BP], positive regulation of sequence-specific DNA binding transcription factor activity [BP], regulation of sequence-specific DNA binding transcription factor activity [BP], regulation of defense response to virus by virus [BP]
CG_h9_promoter_p_RM_12_171_2			3	0.5	4.64E-04	SPTBN4, OPRL1, RIMKLB, HPN, DRD4	citrate-L-glutamate ligase activity [MF], regulation of sodium ion transport [BP], neuronal cell body [CC], olfactory learning [BP], basement membrane disassembly [BP], nociceptin receptor activity [MF], adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway [BP]
CG_h9_promoter_p_RM_12_94_6			3	0.5	2.84E-04	NR2F2	radial pattern formation [BP]
CG_h9_promoter_p_RM_12_187_3			4	0.75	5.20E-04	PALLD, TES, ACTN3	focal adhesion [CC]
CG_h9_promoter_p_RM_12_85_8			3	0.5	3.43E-04	FMN2, CBR1, HIF1A, FOXL1, NKX2-3	meiotic chromosome movement towards spindle pole [BP], neural fold elevation formation [BP], post-embryonic digestive tract morphogenesis [BP], visceral mesoderm-endoderm interaction involved in midgut development [BP], 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [MF], prostaglandin-E2 9-reductase activity [MF]
CG_h9_promoter_p_RM_12_156_9			4	0.75	3.69E-04	TRIM28, TRIM24, SOX8, BOK, CHAF1A, RCC1	oligodendrocyte differentiation [BP], nuclear euchromatin [CC], chromo shadow domain binding [MF], nuclear chromatin [CC]
CG_h9_promoter_p_RM_12_172_3			3	0.5	3.27E-04	GALR1, ENOPH1, PLCG1, SERP2, ADORA2A	glutamate receptor binding [MF], adenylate cyclase-activating G-protein coupled receptor signaling pathway [BP], acireductone synthase activity [MF], protein transport [BP]
CG_h9_promoter_p_RM_12_23_4			3	0.75	1.87E-04	PRPF31, ARHGEF10	positive regulation of GTP catabolic process [BP], snRNP binding [MF], U4atac snRNP [CC], U4 snRNP [CC]
CG_h9_promoter_p_RM_12_126_3			3	0.75	1.54E-04	AGBL5, RIPK1	protein branching point deglutamylation [BP], regulation of ATP:ADP antiporter activity [BP]
CG_h9_promoter_p_RM_12_189_5			3	0.75	4.26E-04	NOS3, TRIM71, FOXP4, GNAS, FOXO3, UHRF1, HOXD9, TSN	protein autoubiquitination [BP], ovulation from ovarian follicle [BP], cellular response to catecholamine stimulus [BP], sequence-specific DNA binding [MF], embryo development [BP], double-stranded DNA binding [MF]
CG_h9_promoter_p_RM_12_112_10			4	0.75	3.70E-04	KDM1A, SLC20A1, TRIM71, EEF2K	elongation factor-2 kinase activity [MF], regulation of neural precursor cell proliferation [BP], regulation of primitive erythrocyte differentiation [BP], high affinity inorganic phosphate:sodium symporter activity [MF], stem cell proliferation [BP]
CG_h9_promoter_p_RM_12_25_6			4	0.75	2.18E-04	IGF1R, PPARA, CRHR1, SLC12A5	G-protein alpha-subunit binding [MF], negative regulation of appetite [BP], learning [BP]
CG_h9_promoter_p_RM_12_17_4			3	0.75	4.11E-04	ZNF143, YAP1, WEE1	nucleoplasm [CC]
CG_h9_promoter_p_RM_12_21_4			3	0.5	1.99E-04	ASS1, DRAXIN, CREBRF	argininosuccinate synthase activity [MF], commissural neuron differentiation in spinal cord [BP], negative regulation of endoplasmic reticulum unfolded protein response [BP]
CG_h9_promoter_p_RM_12_167_4			5	0.75	2.83E-04	PGAP2, NDFIP2, CUX1	Golgi membrane [CC]
CG_h9_promoter_p_RM_12_158_2			2	0.5	1.57E-04	MPG, SLC12A5	DNA-7-methylguanine glycosylase activity [MF], DNA-7-methyladenine glycosylase activity [MF], thermosensory behavior [BP], DNA-3-methylguanine glycosylase activity [MF], DNA-3-methyladenine glycosylase activity [MF]
CG_h9_promoter_p_RM_12_46_5			3	0.75	3.48E-04	UBIAD1	menaquinone biosynthetic process [BP]
CG_h9_promoter_p_RM_12_185_10			4	0.75	2.63E-04	KNDC1, WDYHV1	regulation of dendrite morphogenesis [BP], protein-N-terminal glutamine amidohydrolase activity [MF]
CG_h9_promoter_p_RM_12_124_8			4	0.75	2.01E-04	PRDX5	regulation of apoptosis involved in tissue homeostasis [BP], peroxynitrite reductase activity [MF]
CG_h9_promoter_p_RM_12_88_4			3	0.5	2.91E-04	UBC	nucleotide-binding oligomerization domain containing signaling pathway [BP]
CG_h9_promoter_p_RM_12_98_3			3	0.75	2.11E-04	RAB25	pseudopodium membrane [CC]
CG_h9_promoter_p_RM_14_14_2			1	0.25	5.43E-04	HIST3H2BB, GCC2, HIST1H2BO	nucleosome assembly [BP], late endosome to Golgi transport [BP], nucleosome [CC], recycling endosome to Golgi transport [BP]
CG_h9_promoter_p_RM_12_44_5			3	0.5	3.81E-04	FZD7, SDHAF1	negative regulation of ectodermal cell fate specification [BP], mitochondrial respiratory chain complex II assembly [BP]
CG_h9_promoter_p_RM_12_15_2			3	0.75	3.35E-04	FAM21C, FAM21B, PTGER4	retrograde transport, endosome to Golgi [BP], early endosome membrane [CC], negative regulation of eosinophil extravasation [BP], WASH complex [CC], negative regulation of integrin activation [BP]
CG_h9_promoter_p_RM_12_87_4			2	0.5	2.51E-04	SLC35A1, SLC12A5	CMP-N-acetylneuraminate transport [BP], thermosensory behavior [BP]
CG_h9_promoter_p_RM_12_50_2			3	0.5	3.51E-04	ADCYAP1	positive regulation of somatostatin secretion [BP], pituitary adenylate cyclase-activating polypeptide receptor binding [MF], pituitary adenylate cyclase activating polypeptide activity [MF], negative regulation of acute inflammatory response to non-antigenic stimulus [BP]
CG_h9_promoter_p_RM_12_122_8			5	1.0	3.45E-04	RET, FOXE1	pharynx development [BP], Peyer's patch morphogenesis [BP], posterior midgut development [BP]
CG_h9_promoter_p_RM_12_74_3			2	0.5	1.67E-04	BCL2L11, FAHD1	acylpyruvate hydrolase activity [MF], BIM-BCL-2 complex [CC], fumarylpyruvate hydrolase activity [MF], BIM-BCL-xl complex [CC], acetylpyruvate hydrolase activity [MF]
CG_h9_promoter_p_RM_12_200_10			6	0.75	5.32E-04	HINFP, COG3, HOXC5, MLLT10, RUNX2, UBA5, GLTSCR2, TBX4, IQSEC3, MRTO4, KLHDC2, PKNOX2, CAMK1D	intracellular membrane-bounded organelle [CC], sequence-specific DNA binding transcription factor activity [MF], nucleus [CC]
CG_h9_promoter_p_RM_12_41_7			5	0.5	5.29E-04	ACADS, FN3K	butyrate catabolic process [BP], fructosamine-3-kinase activity [MF], fructoselysine metabolic process [BP], butyryl-CoA dehydrogenase activity [MF]
CG_h9_promoter_p_RM_12_82_5			4	0.75	2.43E-04	FPGS	tetrahydrofolylpolyglutamate synthase activity [MF]
CG_h9_promoter_p_RM_12_114_8			4	0.75	9.76E-05	PRRX2, LDLRAP1, BTRC, PSEN2	embryonic limb morphogenesis [BP], amyloid precursor protein metabolic process [BP], protein phosphorylated amino acid binding [MF], embryonic cranial skeleton morphogenesis [BP]
CG_h9_promoter_p_RM_12_132_5			3	0.75	7.89E-05	PAX2	regulation of metanephros size [BP], negative regulation of apoptotic process involved in metanephric nephron tubule development [BP], optic nerve structural organization [BP], vestibulocochlear nerve formation [BP], positive regulation of optic nerve formation [BP], optic chiasma development [BP], negative regulation of mesenchymal cell apoptotic process involved in metanephros development [BP], pronephric field specification [BP], positive regulation of metanephric DCT cell differentiation [BP], negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis [BP], negative regulation of apoptotic process involved in metanephric collecting duct development [BP]
CG_h9_promoter_p_RM_12_80_3			2	0.5	1.73E-04	NQO2	dihydronicotinamide riboside quinone reductase activity [MF]
CG_h9_promoter_p_RM_12_72_4			5	0.75	8.30E-05	CTCF, GRIN1, STYX, LIG3, MEIG1	spermatogenesis [BP], chromatin insulator sequence binding [MF], propylene metabolic process [BP]
CG_h9_promoter_p_RM_14_18_2			4	0.75	5.19E-04	TSPYL2, SOX12, ERCC6L2, HOXC12, ZIC2, TMEM57, KLHDC2, FOXP4	sequence-specific DNA binding [MF], DNA binding [MF], nucleus [CC]
CG_h9_promoter_p_RM_12_179_2			3	0.5	1.98E-04	ASS1, LYN	alpha2-beta1 integrin complex [CC], positive regulation of dendritic cell apoptotic process [BP], negative regulation of mast cell proliferation [BP], positive regulation of oligodendrocyte progenitor proliferation [BP], argininosuccinate synthase activity [MF]
CG_h9_promoter_p_RM_12_32_4			4	0.75	3.18E-04	MPP5, NFE2L1	anatomical structure morphogenesis [BP], myelin assembly [BP]
CG_h9_promoter_p_RM_12_191_4			3	0.5	3.44E-04	MED12L, SLC9A3R2	beta-catenin binding [MF]
CG_h9_promoter_p_RM_12_27_8			3	0.5	3.68E-04	PAK2, DACT1	synapse organization [BP], protein tyrosine kinase activator activity [MF]
CG_h9_promoter_p_RM_12_136_4			2	0.5	1.81E-04	FZD3, TALDO1, SGCG, RPS3A, C19orf24, SOX1, SKI, SOX4, TROAP, LHX2	glial cell proliferation [BP], neural tube closure [BP], neural tube formation [BP], lens morphogenesis in camera-type eye [BP], cytoplasm [CC]
CG_h9_promoter_p_RM_12_173_4			3	0.5	2.35E-04	PHAX, NDOR1	cellular response to menadione [BP], snRNA export from nucleus [BP]
CG_h9_promoter_p_RM_12_199_2			3	0.5	4.11E-04	MALT1, STAT5A	B-1 B cell differentiation [BP], positive regulation of mast cell differentiation [BP]
CG_h9_promoter_p_RM_12_78_6			2	0.5	3.12E-04	MTHFD2, ATCAY	negative regulation of glutamate metabolic process [BP], methylenetetrahydrofolate dehydrogenase (NAD+) activity [MF]
CG_h9_promoter_p_RM_12_29_4			2	0.5	4.27E-04	PTEN, ZIC2, NLGN3, CHMP2B	postsynaptic density assembly [BP], rhythmic synaptic transmission [BP], cellular membrane organization [BP], long-term synaptic potentiation [BP], cell adhesion molecule binding [MF], negative regulation of cyclin-dependent protein kinase activity involved in G1/S [BP], social behavior [BP], regulation of terminal button organization [BP], negative regulation of synaptic vesicle clustering [BP], dendritic spine morphogenesis [BP], inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [MF], negative regulation of ribosome biogenesis [BP], positive regulation of sequence-specific DNA binding transcription factor activity [BP], phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [MF], positive regulation of excitatory postsynaptic membrane potential [BP], presynaptic membrane assembly [BP], regulation of dendritic spine morphogenesis [BP]
CG_h9_promoter_p_RM_12_197_2			3	0.5	3.98E-04	CBR1	15-hydroxyprostaglandin dehydrogenase (NADP+) activity [MF], prostaglandin-E2 9-reductase activity [MF]
CG_h9_promoter_p_RM_12_182_2			4	0.75	2.61E-04	ZIC3	determination of left/right asymmetry in nervous system [BP]
CG_h9_promoter_p_RM_12_130_2			2	0.5	2.43E-04	CR1	complement component C3b receptor activity [MF], positive regulation of serine-type endopeptidase activity [BP], negative regulation of complement activation, alternative pathway [BP], complement component C4b receptor activity [MF], complement component C3b binding [MF], negative regulation of serine-type endopeptidase activity [BP], complement component C4b binding [MF], negative regulation of complement activation, classical pathway [BP]
CG_h9_promoter_p_RM_12_107_8			6	0.75	3.25E-04	HLX, HAT1, VEGFA, MATR3, SPTBN4, PROX1, PIAS4	positive regulation of organ growth [BP], nuclear matrix [CC], lymph vessel morphogenesis [BP], venous blood vessel morphogenesis [BP]
CG_h9_promoter_p_RM_12_106_2			5	0.75	4.00E-04	DSE	chondroitin-glucuronate 5-epimerase activity [MF]
CG_h9_promoter_p_RM_12_153_7			3	0.5	2.85E-04	SPHK1, PAX2, AANAT	negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis [BP], negative regulation of apoptotic process involved in metanephric nephron tubule development [BP], optic nerve structural organization [BP], vestibulocochlear nerve formation [BP], positive regulation of optic nerve formation [BP], optic chiasma development [BP], negative regulation of mesenchymal cell apoptotic process involved in metanephros development [BP], pronephric field specification [BP], D-erythro-sphingosine kinase activity [MF], sphinganine kinase activity [MF], negative regulation of apoptotic process involved in metanephric collecting duct development [BP], positive regulation of metanephric DCT cell differentiation [BP], sphingoid catabolic process [BP], regulation of metanephros size [BP], melatonin biosynthetic process [BP], aralkylamine N-acetyltransferase activity [MF]
CG_h9_promoter_p_RM_12_121_3			3	0.75	2.53E-04	FGF9, PDZK1, CHRD	positive regulation of mesenchymal cell proliferation [BP], scavenger receptor binding [MF]
CG_h9_promoter_p_RM_14_3_2			3	0.5	4.58E-04	ADM, PFKP, HMOX2, SNX17	heme oxygenase (decyclizing) activity [MF], heme oxidation [BP], 6-phosphofructokinase complex [CC], adrenomedullin receptor binding [MF], receptor-mediated endocytosis [BP]
CG_h9_promoter_p_RM_12_198_5			6	0.75	2.59E-04	PSMD13, SHROOM2, SOX11	proteasome accessory complex [CC], lens morphogenesis in camera-type eye [BP], signal transduction involved in G1/S transition checkpoint [BP]
CG_h9_promoter_p_RM_14_21_2			6	0.75	5.54E-04	TSPYL2, SDCBP, DUSP5	interleukin-5 receptor complex [CC], Ras protein signal transduction [BP], nucleoplasm [CC]
CG_h9_promoter_p_RM_12_149_7			4	0.5	2.44E-04	BTRC, SIVA1, MAL, AP2A1, FSCN2, TPD52L1, LDLRAP1, FSCN1, CASP7	clathrin coat of trans-Golgi network vesicle [CC], protein binding, bridging [MF], activation of cysteine-type endopeptidase activity involved in apoptotic process [BP], protein phosphorylated amino acid binding [MF], activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [BP], apoptotic protease activator activity [MF], AP-2 adaptor complex [CC]
CG_h9_promoter_p_RM_12_186_4			3	0.5	3.55E-04	ITPR3, SPAST, COG3	ER to Golgi vesicle-mediated transport [BP], inositol hexakisphosphate binding [MF]
CG_h9_promoter_p_RM_12_70_4			3	0.75	1.87E-04	FGFR3, NR2F2, SLC6A1	radial pattern formation [BP], epithelial cell fate commitment [BP], gamma-aminobutyric acid import [BP]
CG_h9_promoter_p_RM_12_86_2			2	0.5	1.19E-04	ENOPH1, MYO15A	myosin complex [CC], acireductone synthase activity [MF]
CG_h9_promoter_p_RM_12_47_8			3	0.5	3.62E-04	APLP1, SOX1, HIF1A, NPAS1, FGF18	central nervous system development [BP], positive regulation of vascular endothelial growth factor receptor signaling pathway [BP], lens morphogenesis in camera-type eye [BP], forebrain development [BP]
CG_h9_promoter_p_RM_12_125_4			3	0.5	1.67E-04	ZFPM1	negative regulation of interleukin-4 biosynthetic process [BP], negative regulation of mast cell differentiation [BP]
CG_h9_promoter_p_RM_12_34_7			4	0.5	3.48E-04	DAND5, GREM1	negative regulation of BMP signaling pathway [BP], morphogen activity [MF]
CG_h9_promoter_p_RM_12_1_7			2	0.5	1.29E-04	PBX3, MPG	DNA-7-methylguanine glycosylase activity [MF], DNA-7-methyladenine glycosylase activity [MF], DNA-3-methylguanine glycosylase activity [MF], DNA-3-methyladenine glycosylase activity [MF], anterior compartment pattern formation [BP], posterior compartment specification [BP]
CG_h9_promoter_p_RM_12_195_2			3	0.5	3.16E-04	DNASE1, FAM103A1	recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex [BP], deoxyribonuclease I activity [MF]
CG_h9_promoter_p_RM_12_102_8			3	0.5	2.72E-04	ADORA2A, CHRNB1, SLC7A6	amino acid transport [BP], synaptic transmission, cholinergic [BP]
CG_h9_promoter_p_RM_12_143_5			4	0.5	2.62E-04	PSEN1, ILK, GATA4	epithelial cell fate commitment [BP], substrate adhesion-dependent cell spreading [BP], positive regulation of BMP signaling pathway [BP], dendritic shaft [CC]
CG_h9_promoter_p_RM_12_22_2			2	0.5	2.77E-04	PICK1, SNX24, HTT	retrograde vesicle-mediated transport, Golgi to ER [BP], cytoplasmic vesicle membrane [CC], diazepam binding [MF]
CG_h9_promoter_p_RM_12_13_4			3	0.5	1.99E-04	ENOPH1	acireductone synthase activity [MF]
CG_h9_promoter_p_RM_12_159_5			1	0.25	3.36E-04	RBM15, BCL2L11	spleen development [BP]
CG_h9_promoter_p_RM_12_123_5			4	0.75	3.60E-04	DNAJA3, MERTK, HTRA2, RARA	rhabdomere [CC], pentacyclic triterpenoid metabolic process [BP], Sertoli cell fate commitment [BP], apoptotic cell clearance [BP], actin filament [CC]
CG_h9_promoter_p_RM_12_104_8			6	0.75	3.06E-04	MIB1, OPRL1, CHRD	nuclear membrane [CC], nociceptin receptor activity [MF], BMP signaling pathway involved in spinal cord dorsal/ventral patterning [BP]
CG_h9_promoter_p_RM_12_52_2			2	0.5	6.24E-05	F2	positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway [BP]
CG_h9_promoter_p_RM_12_154_4			2	0.5	3.03E-04	TNKS2, QPCT, SLC3A2	leucine import [BP], peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [BP], protein auto-ADP-ribosylation [BP], tryptophan transport [BP]
CG_h9_promoter_p_RM_12_108_5			3	0.5	2.56E-04	CTCF, BUB3	regulation of chromosome segregation [BP], regulation of histone acetylation [BP], chromatin insulator sequence binding [MF]
CG_h9_promoter_p_RM_12_202_5			4	0.75	4.48E-04	UBXN2A, HOOK3	cis-Golgi network [CC]
CG_h9_promoter_p_RM_12_133_8			5	1.0	4.38E-04	FZD2, GPR50, FZD7, LPHN2, FZD1	regulation of catenin import into nucleus [BP], hard palate development [BP], G-protein coupled receptor signaling pathway [BP], Wnt receptor signaling pathway, calcium modulating pathway [BP], neuron projection membrane [CC], planar cell polarity pathway involved in neural tube closure [BP], Wnt-protein binding [MF], membranous septum morphogenesis [BP], Wnt-activated receptor activity [MF], muscular septum morphogenesis [BP], G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger [BP], PDZ domain binding [MF]
CG_h9_promoter_p_RM_12_207_3			3	0.5	2.99E-04	PPARD	linoleic acid binding [MF]
CG_h9_promoter_p_RM_12_116_7			4	0.75	3.41E-04	BAHCC1, POLR1C, ZNF584, BBX, ARID4A, E2F4	DNA binding [MF]
CG_h9_promoter_p_RM_12_54_2			4	0.5	2.27E-04	MINPP1, BCAM, AQP1, ZMIZ1	positive regulation of fibroblast proliferation [BP], carbon dioxide transmembrane transporter activity [MF], bisphosphoglycerate 3-phosphatase activity [MF], laminin receptor activity [MF], maintenance of symbiont-containing vacuole by host [BP], polyphosphate metabolic process [BP], transepithelial water transport [BP], inositol hexakisphosphate 2-phosphatase activity [MF], carbon dioxide transmembrane transport [BP], nitric oxide transmembrane transporter activity [MF]
CG_h9_promoter_p_RM_12_79_2			2	0.5	3.12E-04	MERTK	transmembrane receptor protein tyrosine kinase activity [MF], rhabdomere [CC]
CG_h9_promoter_p_RM_12_205_4			4	0.75	4.38E-04	PAFAH1B1, FPGS	tetrahydrofolylpolyglutamate synthase activity [MF], astral microtubule [CC]
CG_h9_promoter_p_RM_12_196_3			3	0.75	2.66E-04	RCC1, GRIK2, RB1, PTEN, ORC6	postsynaptic density assembly [BP], S phase of mitotic cell cycle [BP], negative regulation of cyclin-dependent protein kinase activity involved in G1/S [BP], multicellular organismal response to stress [BP], regulation of S phase of mitotic cell cycle [BP], negative regulation of synaptic vesicle clustering [BP], regulation of excitatory postsynaptic membrane potential [BP], positive regulation of synaptic transmission [BP], inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [MF], regulation of mitosis [BP], phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [MF], G1/S transition of mitotic cell cycle [BP], negative regulation of ribosome biogenesis [BP], positive regulation of mitotic metaphase/anaphase transition [BP]
CG_h9_promoter_p_RM_12_138_4			3	0.5	3.67E-04	RAB40C, RASD2, SYDE1, VIL1	cytoplasmic actin-based contraction involved in cell motility [BP], small GTPase mediated signal transduction [BP], lysophosphatidic acid binding [MF]
CG_h9_promoter_p_RM_12_137_3			4	0.75	2.76E-04	LYN, SLC27A1, PLK4, PDPK1, NFKB1	3-phosphoinositide-dependent protein kinase activity [MF], negative regulation of interleukin-12 biosynthetic process [BP], immune response-regulating cell surface receptor signaling pathway [BP], response to insulin stimulus [BP], positive regulation of oligodendrocyte progenitor proliferation [BP], alpha2-beta1 integrin complex [CC], positive regulation of dendritic cell apoptotic process [BP], positive regulation of centriole replication [BP], negative regulation of mast cell proliferation [BP], negative regulation of toll-like receptor signaling pathway [BP], regulation of mast cell degranulation [BP], toll-like receptor signaling pathway [BP], regulation of mast cell activation [BP]
CG_h9_promoter_p_RM_12_188_3			2	0.5	3.83E-04	NR4A1, EPN1, PTEN	postsynaptic density assembly [BP], epidermal growth factor receptor signaling pathway [BP], negative regulation of cyclin-dependent protein kinase activity involved in G1/S [BP], inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [MF], negative regulation of synaptic vesicle clustering [BP], phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [MF], negative regulation of ribosome biogenesis [BP]
CG_h9_promoter_p_RM_14_8_3			4	0.5	2.47E-04	SIM2, PCYOX1, MLL, WNT3A	chloride-transporting ATPase activity [MF], positive regulation of cellular response to drug [BP], positive regulation of canonical Wnt receptor signaling pathway involved in controlling type B pancreatic cell proliferation [BP], positive regulation of mesodermal cell fate specification [BP], prenylcysteine oxidase activity [MF], embryonic pattern specification [BP]
CG_h9_promoter_p_RM_12_62_2			5	0.75	3.08E-04	HPN	basement membrane disassembly [BP]
CG_h9_promoter_p_RM_12_43_9			5	0.5	4.03E-04	ETV2, MMP2, GRN	embryo implantation [BP], BMP signaling pathway involved in mesodermal cell fate specification [BP]
CG_h9_promoter_p_RM_12_131_8			4	0.75	3.07E-04	GATA4, SOX11	enhancer sequence-specific DNA binding [MF], positive regulation of BMP signaling pathway [BP], embryonic digestive tract morphogenesis [BP]
CG_h9_promoter_p_RM_12_127_2			4	0.75	2.12E-04	BCL2L11	BIM-BCL-2 complex [CC], BIM-BCL-xl complex [CC]
CG_h9_promoter_p_RM_12_11_2			3	0.5	3.08E-04	ADORA2B	positive regulation of chronic inflammatory response to non-antigenic stimulus [BP]
CG_h9_promoter_p_RM_14_20_9			6	0.75	5.72E-04	YY1, CDKN2AIP, FMN2, SOX8, KLHDC2, CERS6, NEK7, ZBTB10, CDK13, ZIC2, RNF111, TMEM57, FEM1B, CUL1, POU3F2, TSPYL2, MLLT10, USP15, SDCBP, SSBP4, PKNOX2, SOBP, L3MBTL3, PDE1B, YBX1, FOXC1, KDM1A	sequence-specific DNA binding transcription factor activity [MF], nucleoplasm [CC], multicellular organismal development [BP], regulation of transcription from RNA polymerase II promoter [BP], SUMO polymer binding [MF], nucleus [CC]
CG_h9_promoter_p_RM_12_4_3			3	0.5	3.12E-04	ZNF703, WEE1, SKP2, RIMKLA	regulation of cell cycle [BP], S phase of mitotic cell cycle [BP], cellular protein modification process [BP]
CG_h9_promoter_p_RM_14_2_1			2	0.5	4.13E-04	DERA	deoxyribonucleoside catabolic process [BP], deoxyribose-phosphate aldolase activity [MF]
CG_h9_promoter_p_RM_12_61_5			3	0.5	2.92E-04	NKX2-3, UBC, PLCG2	B cell differentiation [BP], T cell receptor signaling pathway [BP], post-embryonic digestive tract morphogenesis [BP], follicular B cell differentiation [BP], hypothalamus gonadotrophin-releasing hormone neuron development [BP], ubiquitin homeostasis [BP]
CG_h9_promoter_p_RM_12_181_2			3	0.5	3.40E-04	NT5M, GATA3, NIT2	negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation [BP], omega-amidase activity [MF], negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation [BP], negative regulation of cell proliferation involved in mesonephros development [BP], dUMP catabolic process [BP], regulation of histone H3-K27 methylation [BP]
CG_h9_promoter_p_RM_12_69_3			3	0.5	2.81E-04	PAFAH1B1, CTNNA1, MYO7B, PDLIM5	actin binding [MF], neuroblast proliferation [BP], astral microtubule [CC], establishment of centrosome localization [BP], actin cytoskeleton [CC]
CG_h9_promoter_p_RM_12_100_7			5	0.75	3.60E-04	RPS21	endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [BP]
CG_h9_promoter_p_RM_12_168_4			4	0.5	2.84E-04	RPS9, NR2E1	amygdala development [BP], RNA metabolic process [BP]
CG_h9_promoter_p_RM_12_6_5			2	0.5	3.45E-04	FMN2	meiotic chromosome movement towards spindle pole [BP]
CG_h9_promoter_p_RM_12_77_2			4	0.5	2.09E-04	AGAP1, AGAP3, POLR2A, DIO3, SRD5A3, ARL4D, RAB40C, CDC42, SLC44A2	ARF GTPase activator activity [MF], polyprenol catabolic process [BP], RNA-directed RNA polymerase activity [MF], GTP binding [MF], actin filament branching [BP], thyroxine 5-deiodinase activity [MF], cell periphery [CC], small GTPase mediated signal transduction [BP], regulation of ARF GTPase activity [BP], GTP catabolic process [BP], small molecule metabolic process [BP]
CG_h9_promoter_p_RM_12_101_5			4	0.75	1.35E-04	SNTG2	syntrophin complex [CC]
CG_h9_promoter_p_RM_12_81_8			3	0.75	3.18E-04	KDM1B, ZIC2, ISL1	histone demethylase activity (H3-monomethyl-K4 specific) [MF], retinal ganglion cell axon guidance [BP]
CG_h9_promoter_p_RM_12_103_6			5	0.75	2.24E-04	SRRT, TWIST2, UNCX, POLR3B, SALL3, NUSAP1	olfactory bulb interneuron differentiation [BP], DNA binding [MF]
CG_h9_promoter_p_RM_12_71_4			3	0.5	2.08E-04	FOXD3, ISL1	neural crest cell migration [BP], sensory system development [BP]
CG_h9_promoter_p_RM_12_129_2			3	0.5	1.97E-04	SETD1B, JARID2, MAEL, HIF1AN	histone methyltransferase complex [CC], peptidyl-histidine hydroxylation [BP], synapsis [BP], peptidyl-histidine dioxygenase activity [MF], peptidyl-asparagine 3-dioxygenase activity [MF], peptidyl-asparagine hydroxylation [BP]
CG_h9_promoter_p_RM_12_2_9			3	0.75	2.15E-04	CTCF, TOP1, NEFM	microtubule cytoskeleton organization [BP], chromosome segregation [BP]
CG_h9_promoter_p_RM_12_163_3			4	0.75	5.05E-04	PSEN1, KDM1A, HES1	hematopoietic progenitor cell differentiation [BP], telencephalon development [BP], muscle cell development [BP], thymus development [BP]
CG_h9_promoter_p_RM_12_105_3			5	0.75	3.27E-04	DRD4, DOLPP1	dopamine receptor signaling pathway [BP], dolichyldiphosphatase activity [MF]
CG_h9_promoter_p_RM_14_22_2			3	0.75	6.71E-04	DAND5, ACADS	butyrate catabolic process [BP], sequestering of nodal from receptor via nodal binding [BP], butyryl-CoA dehydrogenase activity [MF]
CG_h9_promoter_p_RM_12_119_4			2	0.5	2.96E-04	SLC16A2, SLC16A3	monocarboxylic acid transmembrane transporter activity [MF]
CG_h9_promoter_p_RM_12_204_7			3	0.75	2.81E-04	PPP2R1A, NASP, RGS20, PLEKHG6, IRF4, ZFPM2, PLEKHF2, LRRC1, ADRA2C, ACTR2, PIAS4, TELO2, VEZT, APAF1, TCAP	protein binding [MF], chordate embryonic development [BP], cytoplasm [CC]
CG_h9_promoter_p_RM_12_53_3			3	0.5	3.64E-04	PPP1CB, SLC6A6, AANAT	myosin phosphatase activity [MF], myosin-light-chain-phosphatase activity [MF], taurine:sodium symporter activity [MF], aralkylamine N-acetyltransferase activity [MF], taurine transport [BP]
CG_h9_promoter_p_RM_12_109_3			5	1.0	3.14E-04	ADORA2B, FBXL15, GALR1, SOX11, EDNRA	positive regulation of lens epithelial cell proliferation [BP], negative regulation of cAMP biosynthetic process [BP], positive regulation of hippo signaling cascade [BP], positive regulation of BMP signaling pathway [BP], positive regulation of chronic inflammatory response to non-antigenic stimulus [BP], adenylate cyclase-activating G-protein coupled receptor signaling pathway [BP], activation of adenylate cyclase activity [BP], neural crest cell development [BP]
CG_h9_promoter_p_RM_12_38_8			3	0.75	2.78E-04	KCNS3, SLC38A3, CAD, PIAS3	asparagine transport [BP], aspartate binding [MF], aspartate carbamoyltransferase activity [MF], carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [MF], histidine transport [BP], potassium channel regulator activity [MF], dihydroorotase activity [MF]
CG_h9_promoter_p_RM_12_141_3			3	0.5	3.68E-04	CSE1L, CLP1	importin-alpha export receptor activity [MF], ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity [MF]
CG_h9_promoter_p_RM_12_9_2			3	0.75	1.21E-04	SIVA1, PRPF31	CD27 receptor binding [MF], U4 snRNP [CC], snRNP binding [MF], U4atac snRNP [CC]
CG_h9_promoter_p_RM_12_135_6			2	0.5	2.71E-04	RB1, ADARB1, FOXA3, PDX1, FGF2, PHF17	negative regulation of cell growth [BP], negative regulation of cell proliferation [BP], regulation of lipid kinase activity [BP]
CG_h9_promoter_p_RM_14_11_4			4	0.75	3.40E-04	EPHX2, INPP5D, TIMP1, METRNL, EMC10, SERPINF1, LGALS3, C2, OCRL	4-nitrophenylphosphatase activity [MF], extracellular region [CC], phosphatidylinositol phosphorylation [BP], extracellular matrix [CC], inositol phosphate phosphatase activity [MF], phospholipid dephosphorylation [BP], negative regulation of neutrophil differentiation [BP], phosphatase activity [MF], 10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity [MF], stilbene catabolic process [BP]
CG_h9_promoter_p_RM_14_9_1			3	0.75	2.89E-04	SMCHD1, ULK1	radial glia guided migration of cerebellar granule cell [BP], Barr body [CC], ULK1-ATG13-FIP200 complex [CC], inactivation of X chromosome by DNA methylation [BP]
CG_h9_promoter_p_RM_12_63_5			2	0.5	4.56E-04	YY1	response to prostaglandin F stimulus [BP]
CG_h9_promoter_p_RM_12_90_4			2	0.5	4.99E-04	ID4, KDM1A, HMGA1, SLC9A3R2	RNA polymerase II transcription factor binding [MF], protein complex assembly [BP]
CG_h9_promoter_p_RM_12_59_6			4	0.75	2.77E-04	PCYOX1, TOP1, MOCS3	chloride-transporting ATPase activity [MF], replication fork protection complex [CC], URM1 activating enzyme activity [MF], enzyme active site formation via L-cysteine persulfide [BP], prenylcysteine oxidase activity [MF]
CG_h9_promoter_p_RM_12_48_3			2	0.5	1.28E-04	AATF	negative regulation of superoxide anion generation [BP]
CG_h9_promoter_p_RM_12_134_10			4	0.75	3.53E-04	PROX1, CBFB, CNOT8, GATAD2A, GLI1, FOXQ1	RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF], cerebellar cortex morphogenesis [BP], sequence-specific DNA binding transcription factor activity [MF]
CG_h9_promoter_p_RM_14_13_3			5	0.75	4.31E-04	CYP2F1, TSEN34	tRNA-intron endonuclease activity [MF], naphthalene metabolic process [BP], tRNA-type intron splice site recognition and cleavage [BP], trichloroethylene metabolic process [BP]
CG_h9_promoter_p_RM_12_99_3			3	0.5	2.58E-04	AK7, DOK7, AK4, SYNGR3	adenylate kinase activity [MF], neuromuscular junction [CC]
CG_h9_promoter_p_RM_12_147_2			3	0.5	3.47E-04	FOXL1, GATA4	visceral mesoderm-endoderm interaction involved in midgut development [BP], lung lobe formation [BP]
CG_h9_promoter_p_RM_12_151_10			2	0.5	3.90E-04	EDA, TUFT1, OSR2, PGAM5	ectoderm development [BP], phosphoprotein phosphatase activity [MF], odontogenesis [BP]